Skip to main content
. 2017 Jul 10;2017:1315432. doi: 10.1155/2017/1315432

Table 3.

Summary of clinical efficacy of pSS patients.

JieDuTongLuoShengJin granules + HCQ Placebo + HCQ p value (between-group)
Week 4 Week 12 Week 4 Week 12 Week 4 Week 12
Dryness (0–10) 0.118 0.026
 Mean ± SD 5.1 ± 2.17 3.6 ± 2.41 5.6 ± 2.28 5.2 ± 2.31
 Median (IQR) 5.0 (3.0, 7.0) 3.5 (1.8, 5.3) 6.0 (4.8, 7.3) 5.5 (4.5, 7.0)
p value versus week 0 0.049 0.011 0.214 0.124
Fatigue (0–10) 0.765 0.002
 Mean ± SD 5.2 ± 2.71 3.3 ± 2.00 5.3 ± 2.15 4.9 ± 1.98
 Median (IQR) 5.0 (4.0, 7.3) 3.0 (2.0, 5.0) 5.0 (4.0, 7.0) 5.0 (4.0, 6.3)
p value versus week 0 0.042 0.000 0.090 0.115
Pain (0–10) 0.853 0.322
 Mean ± SD 2.3 ± 1.98 1.5 ± 1.61 2.2 ± 2.43 1.7 ± 2.25
 Median (IQR) 2.5 (0.0, 3.3) 1.0 (0.0, 2.3) 1.5 (0.0, 4.0) 0.5 (0.0, 2.3)
p value versus week 0 0.034 0.006 0.025 0.014
ESSPRI (0–10) 0.217 0.002
 Mean ± SD 4.2 ± 1.60 2.8 ± 1.18 4.4 ± 1.72 3.9 ± 1.63
 Median (IQR) 4.3 (2.7, 5.2) 2.7 (2, 3.7) 4.3 (3.7, 5.0) 3.9 (3, 4.8)
p value versus week 0 0.009 0.000 0.039 0.032
PGA (0–10) 0.716 0.019
 Mean ± SD 5.0 ± 1.75 3.3 ± 1.68 5.4 ± 2.03 4.7 ± 2.01
 Median (IQR) 5.0 (3.0, 6.3) 3.0 (2.0, 5.0) 5.0 (4.0, 7.0) 5.0 (3.0, 6.0)
p value versus week 0 0.008 0.000 0.042 0.016
Salivary flow rate (ml/15 min) 0.613 0.321
 Mean ± SD 0.8 ± 0.71 1.1 ± 0.81 0.7 ± 0.55 0.9 ± 0.57
 Median (IQR) 0.9 (0.2, 1.0) 1.0 (0.6, 1.5) 0.7 (0.3, 1.0) 0.9 (0.8, 1.0)
p value versus week 0 0.085 0.000 0.354 0.049
Schirmer's test (left) (mm/5 min) 0.445 0.527
 Mean ± SD 4.7 ± 3.89 5.0 ± 4.44 3.9 ± 2.78 4.1 ± 2.44
 Median (IQR) 3.0 (2.0, 5.3) 4.0 (2.0, 5.3) 3.0 (2.0, 5.0) 3.3 (2.0, 6.0)
p value versus week 0 0.457 0.284 0.938 0.585
Schirmer's test (right) (mm/5 min) 0.543 0.759
 Mean ± SD 4.5 ± 2.67 5.0 ± 5.15 3.6 ± 1.96 4.1 ± 2.34
 Median (IQR) 4.0 (3.0, 5.0) 4.0 (2.0, 6.0) 3.0 (2.0, 5.0) 4.0 (2.0, 6.0)
p value versus week 0 0.561 0.948 0.202 0.114
BUT (left) (second) 0.527 0.928
 Mean ± SD 3.7 ± 1.87 3.9 ± 1.66 3.0 ± 1.43 3.6 ± 1.36
 Median (IQR) 3.5 (2.0, 4.3) 4.0 (2.8, 5.0) 2.5 (2.0, 3.3) 3.0 (2.8, 4.3)
p value versus week 0 0.717 0.663 0.776 0.108
BUT (right) (second) 0.474 0.873
 Mean ± SD 3.6 ± 1.38 3.6 ± 1.39 3.2 ± 1.15 3.4 ± 1.50
 Median (IQR) 3.0 (3.0, 4.0) 3.5 (3.0, 4.3) 3.0 (2.0, 4.0) 3.5 (2.0, 5.0)
p value versus week 0 0.490 0.479 0.763 0.299
van Bijsterveld (left) (score) 0.542 0.588
 Mean ± SD 3.2 ± 1.50 3.5 ± 1.93 3.5 ± 1.67 3.1 ± 1.80
 Median (IQR) 3.0 (2.0, 4.0) 3.5 (2.0, 5.0) 3.0 (2.8, 4.3) 3.0 (1.8, 4.3)
p value versus week 0 0.460 0.877 0.720 0.769
van Bijsterveld (right) (score) 0.800 0.631
 Mean ± SD 3.4 ± 1.60 3.4 ± 1.90 3.5 ± 1.67 3.2 ± 1.76
 Median (IQR) 3.5 (2.8, 4.0) 3.5 (2.0, 4.3) 3.5 (2.8, 4.3) 3.0 (2.0, 4.3)   
p value versus week 0 0.482 0.456 0.550 0.919
ESSDAI (0–124) 0.790
 Mean ± SD 2.0 ± 1.10 1.8 ± 1.46
 Median (IQR) 2.0 (1.0, 3.0) 2.0 (1.0, 3.0)
p value versus week 0 0.003 0.016
IgG (g/L) 0.857
 Mean ± SD 16.7 ± 2.39 17.3 ± 5.77
 Median (IQR) 17.3 (15.3, 18.9) 16.2 (14.7, 17.0)
p value versus week 0 0.010 0.096
C3 (g/L) 0.878
 Mean ± SD 1.0 ± 0.16 0.9 ± 0.18
 Median (IQR) 1.0 (0.9, 1.0) 0.9 (0.8, 1.0)
p value versus week 0 0.054 0.101
C4 (g/L) 0.616
 Mean ± SD 0.2 ± 0.05 0.2 ± 0.05
 Median (IQR) 0.2 (0.2, 0.3) 0.2 (0.2, 0.2)
p value versus week 0 0.065 0.087
ESR (mm/h) 0.371
 Mean ± SD 24.4 ± 16.15 26.1 ± 20.93
 Median (IQR) 22.0 (14.0, 31.0) 21.5 (14.0, 30.5)
p value versus week 0 0.001 0.049
CRP (mg/L) 0.807
 Mean ± SD 3.3 ± 1.97 4.4 ± 5.91
 Median (IQR) 2.0 (1.9, 4.3) 2.9 (1.8, 5.8)
p value versus week 0 0.391 0.605